- Latest available (Revised)
- Original (As made)
There are multiple versions of this provision on screen. These apply to different geographical extents.
The term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section.
Sometimes the text of a provision is changed, but the change(s) only apply to a particular geographical area. In some limited cases where this happens, the editorial team create a version for each different geographical area. Multiple versions are only created in this way where the change in question is a substitution so that there are different versions of the text for the different extents. Insertions and repeals of text do not give rise to such multiple versions.
There are currently no known outstanding effects for the The Veterinary Medicines Regulations 2013, Paragraph 1.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
1.—(1) There shall be the following categories of authorised veterinary medicinal products—
(a)Prescription Only Medicine–Veterinarian (abbreviated to POM-V);
(b)Prescription Only Medicine–Veterinarian, Pharmacist, Suitably Qualified Person (abbreviated to POM-VPS);
(c)Non-Food Animal–Veterinarian, Pharmacist, Suitably Qualified Person (abbreviated to NFA-VPS);
(d)Authorised Veterinary Medicine–General Sales List (abbreviated to AVM-GSL).
(2) The Secretary of State must specify the classification of the veterinary medicinal product when granting the initial marketing authorisation.
(3) The Secretary of State may change the classification after the marketing authorisation has been granted, either at the request of the marketing authorisation holder or in accordance with paragraph 37 of Schedule 1 (compulsory variation).
(4) When granting the marketing authorisation the Secretary of State must classify the following as POM-V—
(a)products containing narcotic or psychotropic substances;
(b)products intended for administration following a diagnosis or clinical assessment by a veterinary surgeon;
[F1(c)products containing an antimicrobial;
(d)products for the purpose of euthanasia;
(e)products with a hormonal or thyrostatic function;
(f)products containing beta-agonists].
(5) When granting the marketing authorisation the Secretary of State must classify the following as POM-V or POM-VPS—
(a)products for food-producing animals;
(b)products in respect of which special precautions must be taken in order to avoid any unnecessary risk to—
(i)the target species;
(ii)the person administering the products to the animal; and
(iii)the environment;
(c)products that may cause effects that impede or interfere with subsequent diagnostic or therapeutic measures; F2...
(d)[F3immunological veterinary medicinal products.]
(6) The requirement in sub-paragraph (5)(a) relating to veterinary medicinal products for food-producing animals does not apply if all the following criteria are met—
(a)the administration of the veterinary medicinal product is restricted to formulations requiring no particular knowledge or skill in using the product;
(b)the veterinary medicinal product does not present a direct or indirect risk, even if administered incorrectly, to the animal or animals treated, to the person administering the product or to the environment;
(c)the summary of product characteristics of the veterinary medicinal product does not contain any warnings of potential serious side effects deriving from its correct use;
(d)neither the veterinary medicinal product nor any other product containing the same active substance has previously been the subject of frequent serious [F4adverse event] reporting;
(e)the summary of product characteristics does not refer to contra-indications related to other veterinary medicinal products commonly used without prescription;
(f)the veterinary medicinal product is not subject to special storage conditions;
(g)there is no risk for consumer safety as regards residues in food obtained from treated animals even where the veterinary medicinal products are used incorrectly; and
(h)there is no risk to human or animal health as regards the development of resistance to [F5antibiotics] or anthelmintic substances even where the veterinary medicinal products containing those substances are used incorrectly.
Extent Information
E1This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only
Textual Amendments
F1Sch. 3 para. 1(4)(c)-(f) inserted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 95(a)
F2Word in Sch. 3 para. 1(5)(c) omitted (E.W.S.) (17.5.2024) by virtue of The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 95(b)(i)
F3Sch. 3 para. 1(5)(e) inserted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 95(b)(ii)
F4Words in Sch. 3 para. 1(6)(d) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 95(c)(i)
F5Word in Sch. 3 para. 1(6)(h) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 95(c)(ii)
1.—(1) There shall be the following categories of authorised veterinary medicinal products—
(a)Prescription Only Medicine–Veterinarian (abbreviated to POM-V);
(b)Prescription Only Medicine–Veterinarian, Pharmacist, Suitably Qualified Person (abbreviated to POM-VPS);
(c)Non-Food Animal–Veterinarian, Pharmacist, Suitably Qualified Person (abbreviated to NFA-VPS);
(d)Authorised Veterinary Medicine–General Sales List (abbreviated to AVM-GSL).
(2) The Secretary of State must specify the classification of the veterinary medicinal product when granting the initial marketing authorisation.
(3) The Secretary of State may change the classification after the marketing authorisation has been granted, either at the request of the marketing authorisation holder or in accordance with paragraph 37 of Schedule 1 (compulsory variation).
(4) When granting the marketing authorisation the Secretary of State must classify the following as POM-V—
(a)products containing narcotic or psychotropic substances;
(b)products intended for administration following a diagnosis or clinical assessment by a veterinary surgeon.
(5) When granting the marketing authorisation the Secretary of State must classify the following as POM-V or POM-VPS—
(a)products for food-producing animals;
(b)products in respect of which special precautions must be taken in order to avoid any unnecessary risk to—
(i)the target species;
(ii)the person administering the products to the animal; and
(iii)the environment;
(c)products that may cause effects that impede or interfere with subsequent diagnostic or therapeutic measures; and
(d)new veterinary medicinal products containing an active substance that has not been included in an authorised veterinary medicinal product for five years.
(6) The requirement in sub-paragraph (5)(a) relating to veterinary medicinal products for food-producing animals does not apply if all the following criteria are met—
(a)the administration of the veterinary medicinal product is restricted to formulations requiring no particular knowledge or skill in using the product;
(b)the veterinary medicinal product does not present a direct or indirect risk, even if administered incorrectly, to the animal or animals treated, to the person administering the product or to the environment;
(c)the summary of product characteristics of the veterinary medicinal product does not contain any warnings of potential serious side effects deriving from its correct use;
(d)neither the veterinary medicinal product nor any other product containing the same active substance has previously been the subject of frequent serious adverse reaction reporting;
(e)the summary of product characteristics does not refer to contra-indications related to other veterinary medicinal products commonly used without prescription;
(f)the veterinary medicinal product is not subject to special storage conditions;
(g)there is no risk for consumer safety as regards residues in food obtained from treated animals even where the veterinary medicinal products are used incorrectly; and
(h)there is no risk to human or animal health as regards the development of resistance to antimicrobials or anthelmintic substances even where the veterinary medicinal products containing those substances are used incorrectly.
Extent Information
E2This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: